Keolie supply best xeljanz tofacitinib citrate price

Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

In November 2012, the U.S. FDA approved tofacitinib citrate "to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response to, or who are intolerant of, methotrexate." It was later approved in Japan, Switzerland and others.

 Tofacitinib is used for the treatment of rheumatoid arthritis (RA), and is being studied for treatment of psoriasis, inflammatory bowel disease, and other immunological diseases. Also Tofacitinib is used for the prevention of organ transplant rejection.

Product Name: Tofacitinib citrate Synonyms: 1-PIPERIDINEPROPANENITRILE,

4-METHYL-3-(METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN -4-YLAMINO)-BETA-

OXO-, (3R,4R)-,2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE (1:1);1-

Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-

β-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tofacitinib citrate

(CP-690550);Tofacitinib citrate;Tasocitinib citrate;Tasocitinib citric acids...;Xeljanz;CP-690550 (Tofacitinib citrate) CAS: 540737-29-9

MF: C16H20N6O.C6H8O7

MW: 504.497